CHIEF BUSINESS OFFICER
Dr. Isabel Ferreira joined Versameb in August 2019 as Chief Business Officer. Previously, she served Roche Partnering since 2015 as Director Global Business Development. In this role, she had broad responsibility across Pharma Business Development including strategy, search, evaluation, senior stakeholder management, leading cross-functional due diligence and negotiation teams to deal closure. Before joining Roche, Isabel served as Senior Director Business Development at Prosensa. During this time, she was instrumental in establishing transformative licensing transactions, supporting non-dilutive and private financing events, project management of Prosensa’s IPO launch at NASDAQ and supporting Prosensa’s acquisition by BioMarin. Earlier in her career, Isabel has been exposed to different aspects of the biopharmaceutical industry at Janssen-Cilag (Portugal), OctoPlus (The Netherlands) and Theravance (USA) in commercial, drug development and scientific roles. Isabel holds a Ph.D. in Biochemistry from the University of Groningen (The Netherlands) and an MBA from the Rotterdam School of Management (RSM), Erasmus University (The Netherlands).